Norway· NO-ID_1CB25273-81AD-4A6F-9AE0-82DF0EB5318C
Varivax
A varicella, live attenuated product containing varicella virus oka/merck strain, (live, attenuated) produced in human diploid (mrc-5) cells, registered in Norway by Merck Sharp & Dohme B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Varicella, live attenuated is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BK01 (varicella, live attenuated), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Varicella, live attenuated · ATC J07BK01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Varicella Virus Oka/Merck Strain, (Live, Attenuated) Produced In Human Diploid (Mrc-5) Cells
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Norway (NO)
- ATC code
- J07BK01
- ATC class
- Varicella, live attenuated
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_1CB25273-81AD-4A6F-9AE0-82DF0EB5318C
- no_varenummer5768561NOK 605.7
- gtin3614185768562
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BK01
Varicella, live attenuated, as other registers publish it.
- NetherlandsProvarivax, poeder en oplosmiddel voor suspensie voor injectie in een voorgevulde spuitMerck Sharp & Dohme B.V.
- NetherlandsPROVARIVAX, poeder en oplosmiddel voor suspensie voor injectie in een voorgevulde spuitMedcor Pharmaceuticals B.V.
- BelgiumVarilrixGlaxoSmithKline Biologicals
- SwitzerlandVarilrix
- DenmarkVarilrixGlaxoSmithKline Pharma A/S
- FinlandVarilrixOrifarm Oy
- BelgiumVarilrixGlaxoSmithKline Biologicals
- PolandVarilrixGlaxoSmithKline Biologicals S.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b331b377-c52b-4468-9c8b-f188eb9949cf GET /v1/drugs/b331b377-c52b-4468-9c8b-f188eb9949cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Varicella, levende, svekket",
"merkevare_id": "ID_1CB25273-81AD-4A6F-9AE0-82DF0EB5318C",
"name_form_strength": "Varivax pulv+væske til inj susp > 1350 PFU/dose",
"prescription_group": "C"
}See everything about varicella, live attenuated.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.